These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25795640)

  • 1. Evaluation of Patient Satisfaction After Using Prefilled Insulin Pen in Real Life in Lithuania.
    Radzevičienė L; Apanavičienė DA
    J Diabetes Sci Technol; 2015 Jul; 9(4):939-40. PubMed ID: 25795640
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.
    Siegmund T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1235-7. PubMed ID: 22027324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N; Czupryniak L; Genestin E; Sourij H
    J Diabetes Sci Technol; 2011 Sep; 5(5):1224-34. PubMed ID: 22027323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of patient acceptance and safety of a prefilled insulin injection device.
    Kroon L
    J Diabetes Sci Technol; 2009 Nov; 3(6):1439-41. PubMed ID: 20144399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.
    Pfützner A; Forst T; Niemeyer M; Bailey T
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine.
    Gottesman I; Perron P; Berard L; Stewart J; Basso N; Mettimano K; Elliott T
    Diabetes Technol Ther; 2012 Oct; 14(10):926-35. PubMed ID: 22775367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the SoloSTAR insulin pen device: design verification and validation.
    Bode A
    Expert Opin Drug Deliv; 2009 Jan; 6(1):103-12. PubMed ID: 19236211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A; Asakura T; Sommavilla B; Lee W
    Expert Opin Drug Deliv; 2008 Aug; 5(8):915-25. PubMed ID: 18713000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin pen devices on the management of diabetes mellitus.
    Meece J
    Am J Health Syst Pharm; 2008 Jun; 65(11):1076-82. PubMed ID: 18499883
    [No Abstract]   [Full Text] [Related]  

  • 16. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia.
    Carter J; Beilin J; Morton A; De Luise M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1425-38. PubMed ID: 20144398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D; Narendran P; Qvist M; Niemeyer M; Nadeau DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1259-69. PubMed ID: 21905942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.